CSS
TMDX icon

Cubist Systematic Strategies’s Transmedics TMDX Stock Holding History

Cubist Systematic Strategies’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.33M Sell
20,800
-7,200
-26% -$843K 0.01% 1470
2025
Q2 		$3.75M Sell
28,000
-8,900
-24% -$977K 0.02% 1196
2025
Q1 		$2.48M Buy
36,900
+31,600
+596% +$2.17M 0.02% 1295
2024
Q4 		$330K Sell
5,300
-37,900
-88% -$3.53M ﹤0.01% 2358
2024
Q3 		$6.78M Buy
43,200
+18,600
+76% +$2.87M 0.04% 659
2024
Q2 		$3.71M Buy
24,600
+9,100
+59% +$1.09M 0.03% 959
2024
Q1 		$1.15M Buy
15,500
+10,400
+204% +$857K 0.01% 2065
2023
Q4 		$403K Buy
+5,100
New +$308K ﹤0.01% 2638

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's TMDX Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 164,065 shares — an estimated $11.3M sold.

Cubist Systematic Strategies first reported a position in TMDX in Q2 2019 and held it in 14 quarters. The position peaked at $10.2M in Q4 2024. 299 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 164,065 Transmedics shares in Q1 2025, an estimated $11.3M.
  • Cubist Systematic Strategies first reported a position in Transmedics in Q2 2019 and held it in 14 quarters.
  • Cubist Systematic Strategies's Transmedics position peaked at $10.2M in Q4 2024.
  • 299 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.